Le Lézard
Classified in: Health

UNITED DIGESTIVE LAUNCHES COMPREHENSIVE COLON CANCER AWARENESS CAMPAIGN


Driving Change and Saving Lives Through Awareness and Innovative Screening Efforts

ATLANTA, March 1, 2024 /PRNewswire/ -- In honor of Colon Cancer Awareness Month, United Digestive, on behalf of its many partner practices, is spearheading several events and activities in March as part of a comprehensive public awareness campaign to educate the public, promote screenings, and honor those impacted by colon cancer.

These efforts come on the heels of a new report by the American Cancer Society in January that colon and rectal cancers have become leading causes of cancer death in younger adults. Colorectal cancer is already the deadliest cancer for men under 50 and the second deadliest cancer (behind breast cancer) for women in the same age group.

"As a physician, I have witnessed firsthand the devastating impact of colon cancer on individuals and families," says Dr. Neal C. Patel, president of United Digestive. "It is crucial for the public to understand the seriousness of this disease and the importance of screening and preventative benefits of colonoscopy."

United Digestive's campaign for Colon Cancer Awareness Month involves several initiatives throughout the communities it serves, partnerships with area non-profit organizations, and patient communications by way of "Don't Miss the Signs" PSA, directing patients to screen4coloncancer.com.

Concerning United Digestive's initiatives, Dr. Patel adds, "United Digestive continues to be on the frontlines in raising public awareness about the dangers of colon cancer and the need for preventative measures. We hope our innovative efforts spur individuals to take proactive steps to protect their health by scheduling a colonoscopy with one of our partner practices, who use the latest technology ? including AI-assisted colonoscopies ? to deliver state-of-the-art care."

For additional information about United Digestive, please visit uniteddigestive.com or screen4coloncancer.com.

About United Digestive

United Digestive is a leading physician practice management organization serving GI physicians and gastroenterology practices nationwide. Practices that are part of United Digestive benefit from advanced infrastructure and operational insights, along with investments in regional growth. Physician Partners enjoy a dyad leadership model with reduced administrative burden and local support to provide the highest-quality patient care. United Digestive is growing at a rapid pace, with more than 62 clinics, 22 ASCs, and 300 providers practicing in four states ? Georgia, Florida, North Carolina, and South Carolina.? 

Contact: 
Lance Wagner
Director, Marketing & Communication
[email protected]
404-888-7575 x1130

SOURCE United Digestive


These press releases may also interest you

at 19:50
Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer's 35th...

at 18:59
The news release, U.S. FDA approves Celltrion's AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®, issued 30-Jan-2025 by Celltrion over PR Newswire, has been updated to ensure accuracy of the availability timing of AVTOZMA® (CT-P47,...

at 18:45
Product: Original Mini Ritz CrackersIssue: Food ? Allergen - MilkDistribution: National See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 18:20
Bioceres Crop Solutions Corp. (Bioceres) , a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for...

at 17:31
DelveInsight's Herpes Simplex Market Insights report includes a comprehensive understanding of current treatment practices, herpes simplex emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034,...

at 16:40
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that, in connection with the appointment of the Company's...



News published on and distributed by: